0 Evaluaciones

ID

28295

Descripción

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Subject status and major events

Palabras clave

  1. 12/10/17 12/10/17 -
  2. 16/10/17 16/10/17 -
  3. 23/10/17 23/10/17 -
  4. 2/1/18 2/1/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

2 de enero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Subject status and major events GSK study Chronic Coronary Heart Disease NCT00799903

    Subject status and major events GSK study Chronic Coronary Heart Disease NCT00799903

    Subject status and major events
    Descripción

    Subject status and major events

    1. Has the subject experienced a cardiac endpoint event (MI or UA requiring hospitalization) since the last visit?
    Descripción

    Yes - complete SAE and MI or ANG endpoint form

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C1320716
    2. Has the subject experienced a stroke / TIA event since the last visit?
    Descripción

    Yes - complete SAE and Stroke/TIA endpoint form

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C3844446
    3. Has the subject been hospitalized for heart failure since the last visit?
    Descripción

    Yes - complete SAE and Hospitalisation for Heart Failure endpoint form

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0019993
    UMLS CUI [1,2]
    C0581377
    4. Has the subject undergone a coronary revascularisation since the last visit?
    Descripción

    Yes - complete SAE and Revascularisation endpoint form

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0877341
    UMLS CUI [1,2]
    C1532338
    5. Has the subject been hospitalized for a non-coronary ischemic event since the last visit?
    Descripción

    Yes - complete SAE and Other Endpoint form

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C1956346
    UMLS CUI [1,2]
    C0151744
    6. Has the subject undergone a non-coronary revascularisation since the last visit?
    Descripción

    Yes - complete SAE and Other Endpoint form

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0877341
    UMLS CUI [1,2]
    C0543467
    7. Has the subject undergone a limb amputation due to vascular cause since the last visit?
    Descripción

    Yes - complete SAE and Other Endpoint form

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0002689
    8. Has the subject been diagnosed with new onset diabetes since the last visit?
    Descripción

    Yes - record details on New Onset Diabetes form, and the Non-Serious Adverse Event or Serious Adverse Event form, as appropriate

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0746890
    UMLS CUI [1,2]
    C0011849
    9. Has the subject been diagnosed with new cancer, recurrence of an existing cancer, progression of cancer (=new metastases or new spread) or a benign gastrointestinal polyp(s)/neoplasm(s) since the last visit?
    Descripción

    Yes - record details on Cancer/GI Neoplasm/Polyp Report form and the Non-Serious Adverse Event or Serious Adverse Event form, as appropriate

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0006826
    10. Has the subject had any GI endoscopic procedures (upper or lower) or GI capsule studies performed since the last time the form was updated?
    Descripción

    Yes - complete the GI procedures form. Note: If question is being asked for the first time please report GI endoscopic procedure(s) that have been performed from randomization visit until this visit. If question has already been answered at an earlier visit then only refer back to the last time this question was asked.

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0282493
    11. Were any cardiovascular diagnostic procedures that were related to endpoint events performed since the last visit?
    Descripción

    Yes - record details on the Cardiovascular Diagnostic Procedures form

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0430022
    12. Since the last visit, did the subject experience SAE assessed as related to IP, study participation, or a GSK concomitant medication?
    Descripción

    Yes - complete Serious Adverse Event form

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C1519255

    Similar models

    Subject status and major events GSK study Chronic Coronary Heart Disease NCT00799903

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Subject status and major events
    Item
    1. Has the subject experienced a cardiac endpoint event (MI or UA requiring hospitalization) since the last visit?
    text
    C1320716 (UMLS CUI [1])
    Code List
    1. Has the subject experienced a cardiac endpoint event (MI or UA requiring hospitalization) since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    2. Has the subject experienced a stroke / TIA event since the last visit?
    text
    C3844446 (UMLS CUI [1])
    Code List
    2. Has the subject experienced a stroke / TIA event since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    3. Has the subject been hospitalized for heart failure since the last visit?
    text
    C0019993 (UMLS CUI [1,1])
    C0581377 (UMLS CUI [1,2])
    Code List
    3. Has the subject been hospitalized for heart failure since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    4. Has the subject undergone a coronary revascularisation since the last visit?
    text
    C0877341 (UMLS CUI [1,1])
    C1532338 (UMLS CUI [1,2])
    Code List
    4. Has the subject undergone a coronary revascularisation since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    5. Has the subject been hospitalized for a non-coronary ischemic event since the last visit?
    text
    C1956346 (UMLS CUI [1,1])
    C0151744 (UMLS CUI [1,2])
    Code List
    5. Has the subject been hospitalized for a non-coronary ischemic event since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    6. Has the subject undergone a non-coronary revascularisation since the last visit?
    text
    C0877341 (UMLS CUI [1,1])
    C0543467 (UMLS CUI [1,2])
    Code List
    6. Has the subject undergone a non-coronary revascularisation since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    7. Has the subject undergone a limb amputation due to vascular cause since the last visit?
    text
    C0002689 (UMLS CUI [1])
    Code List
    7. Has the subject undergone a limb amputation due to vascular cause since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    8. Has the subject been diagnosed with new onset diabetes since the last visit?
    text
    C0746890 (UMLS CUI [1,1])
    C0011849 (UMLS CUI [1,2])
    Code List
    8. Has the subject been diagnosed with new onset diabetes since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    9. Has the subject been diagnosed with new cancer, recurrence of an existing cancer, progression of cancer (=new metastases or new spread) or a benign gastrointestinal polyp(s)/neoplasm(s) since the last visit?
    text
    C0006826 (UMLS CUI [1])
    Code List
    9. Has the subject been diagnosed with new cancer, recurrence of an existing cancer, progression of cancer (=new metastases or new spread) or a benign gastrointestinal polyp(s)/neoplasm(s) since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    10. Has the subject had any GI endoscopic procedures (upper or lower) or GI capsule studies performed since the last time the form was updated?
    text
    C0282493 (UMLS CUI [1])
    Code List
    10. Has the subject had any GI endoscopic procedures (upper or lower) or GI capsule studies performed since the last time the form was updated?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    11. Were any cardiovascular diagnostic procedures that were related to endpoint events performed since the last visit?
    text
    C0430022 (UMLS CUI [1])
    Code List
    11. Were any cardiovascular diagnostic procedures that were related to endpoint events performed since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    12. Since the last visit, did the subject experience SAE assessed as related to IP, study participation, or a GSK concomitant medication?
    text
    C1519255 (UMLS CUI [1])
    Code List
    12. Since the last visit, did the subject experience SAE assessed as related to IP, study participation, or a GSK concomitant medication?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial